67 Evers PD, et al Diagnostic approach in fetal coarctation of the aorta: a cost-utility analysis J Am Soc Echocardiogr 2017;30(6):589–594 68 Vogel M, et al Fetal diagnosis of interrupted aortic arch Am J Cardiol 2010;105(5):727–734 69 Slodki M, et al The three-vessel view in the fetal mediastinum in the diagnosis of interrupted aortic arch Ultrasound Med Biol 2011;37(11):1808–1813 70 Campbell M Natural history of coarctation of the aorta Heart 1970;32(5):633–640 71 Hodes HL, Steinfeld L, Blumenthal S Congenital cerebral aneurysms and coarctation of the aorta Arch Pediatr 1959;76(1):28–43 72 Reifenstein GH, Levine SA, Gross RE Coarctation of the aorta; a review of 104 autopsied cases of the adult type, 2 years of age or older Am Heart J 1947;33(2):146–168 73 Roberts WC, Morrow AG, Braunwald E Complete interruption of the aortic arch Circulation 1962;26(1):39–59 74 Freedom RM, et al Ventricular septal defect in interruption of aortic arch Am J Cardiol 1977;39(4):572–582 75 Kramer H-H, et al Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease Eur J Pediatr 1995;154(9):700–707 76 Huang FK, et al Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation Pediatr Neonatol 2013;54(2):102–106 77 Yucel IK, et al Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease Cardiol Young 2015;25(1):56–62 78 Freed MD, et al Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease Circulation 1981;64(5):899–905 79 Jonas RA Management of interrupted aortic arch Semin Thorac Cardiovasc Surg 2015;27(2):177–188 80 Lewis AB, Takahashi M, Lurie PR Administration of prostaglandin E1 in neonates with critical congenital cardiac defects J Pediatr 1978;93(3):481–485 81 Carroll SJ, et al Efficacy of prostaglandin E1 in relieving obstruction in coarctation of a persistent fifth aortic arch without opening the ductus arteriosus Pediatr Cardiol 2006;27(6):766–768 82 Liberman L, et al Effectiveness of prostaglandin E1 in relieving obstruction in coarctation of the aorta without opening the ductus arteriosus Pediatr Cardiol 2004;25(1):49–52 83 Lupoglazoff JM, et al Therapeutic strategy in newborn infants with multivisceral failure caused by interruption or hypoplasia of the aortic arch Arch Mal Coeur Vaiss 1995;88(5):725–730 84 McDonald-McGinn DM, Sullivan KE Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) Medicine (Baltimore) 2011;90(1):1– 18 85 Kobrynski LJ, Sullivan KE Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes Lancet 2007;370(9596):1443–1452 86 Bacha EA, et al Surgery for coarctation of the aorta in infants weighing less than 2 kg Ann Thorac Surg 2001;71(4):1260–1264 87 Fesseha AK, et al Neonates with aortic coarctation and cardiogenic shock: presentation and outcomes Ann Thorac Surg 2005;79(5):1650–1655 88 Bouzguenda I, et al Percutaneous treatment of neonatal aortic coarctation presenting with severe left ventricular dysfunction as a bridge to surgery Cardiol Young 2009;19(3):244–251 89 Blalock A, Park EA The surgical treatment of experimental coarctation of the aorta Ann Surg